The Current Situation and Management of Omicron with Children in Russia: A Review
International Journal of TROPICAL DISEASE & Health,
Omicron is a newly discovered new variant virus, which spreads rapidly around Russia and the world and has a great impact. It is designated as a variant of concern (VOC) by the World Health Organization. Its characteristic of epidemiology, distribution, pathogenic and clinical diagnosis, treatment, and prevention is still being observed and summarized, and Clinical manifestations of COVID-19 infection are nonspecific, especially in preterm infants. Since there are few reports on the diagnosis and treatment of children with this infection. This article studies the diagnosis, treatment, and prevention of omicron in Russian children, to improve the understanding and attention to the disease.
How to Cite
Available:https://covid19.who.int/region/euro/country/ru Accessed 20 Oct 2022.
Worldometer. Reported Cases and Deaths by Country or Territory [EB/OL].
Available:https://www.worldometers.info/coronavirus/ Accessed 20 Oct 2022.
Yandex, DataLens. All known cases in Russia [EB/OL].
Access on 22 Oct 2022.
Derhami S, Rahmani S, Jalalimanesh N. Are children less susceptible to COVID-19? A case series. Mashhad University of Medical Sciences; 2020.
HKUMed finds Omicron SARS-CoV-2 can infect faster and better than Delta in human bronchus but with less severe infection in lung [Internet]. The University of Hong Kong.[EB/OL]
Available:https://www.med.hku.hk/en/news/press/20211215-omicron-sars-cov-2-infection,2021-12-22 HKU Med Access on 20 Oct 2022.
Liguoro I, Pilotto C, Bonanni M et al. SARS-COV-2 infection in children and newborns: A systematic review. Eur J Pediatr. 2020;179:1029-1046.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
Púa Torrejón RC, Ordoño Saiz MV, González Alguacil E, et al. Smell and taste dysfunction in pediatric patients with sars-cov-2 infection. Pediatr Neurol. 2022;136: 28-33.
Gruber CN, Patel RS, Trachtman R, et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell. 2020;183:982-995.e914.
Sultan K, Mone A, Durbin L, et al. Review of inflammatory bowel disease and COVID-19. World Journal of Gastroenterology. 2020;26:9.
Pinto IMC, Helito AC, Fonseca RLA, et al. Comparison between pediatric patients with and without close contact with COVID-19 in a Brazilian city during SARS-CoV-2 pandemics. Clin Pediatr (Phila). 2022;99228221124662.
JF L. Convulsions in children with COVID-19 during the Omicron wave. Acta Paediatr 2022.
Nascimento RB, Araujo NS, Silva JC, Xavier FCA. Oral manifestations of multisystemic inflammatory syndrome in children (MIS-C) and kawasaki disease associated to COVID-19: A systematic review. Spec Care Dentist. 2022;42:266-280.
Liu Y, Yang S, Zeng Y et al. Influence of the COVID-19 pandemic on the prevalence pattern of allergens. int arch allergy immunol. 2022;1-11.
Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur Respir J. 2022;59:2101341.
Wang L BN, Kaelber DC, Davis PB, Volkow ND, Xu R. . Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron. MedRxiv 2022; 2021.2012.2030.21268495.
Hamidi OP, Lijewski V, Sheeder J et al. Adverse perinatal outcomes in pregnancies affected by severe COVID-19 infection. AJOG Glob Rep. 2022;2:100118.
Liu Y, Zhao S, Ryu S et al. Estimating the incubation period of SARS-CoV-2 Omicron BA.1 variant in comparison with that during the delta variant dominance in South Korea. One Health. 2022;15:100425.
Distributed via the CDC health alert network. New SARS-CoV-2 variant of concernidentified:Omicron(B.1.1.529) variant. [EB/OL].
Access on 20 Oct 2022.
Butt AA, Dargham SR, Loka S et al. Coronavirus disease 2019 disease severity in children infected with the omicron variant. Clin Infect Dis. 2022;75:e361-e367.
The Order of the Ministry of Health of Russian Federation, December 6, 2021 №1122n "On approval of the national calendar of preventive vaccinations, the calendar of preventive vaccinations on epidemic indications, and the procedure for preventive vaccinations implementation" was registered in Ministry of Justice of Russian Federation on December 20, 2021, registration №66435, came into on December 31, 2021.[EB/OL]. Официальный интернет-портал правовойинформации
Access on 20 Oct 2022.
Национальные, приоритеты. Operational data [EB/OL].
Access on 22 Oct 2022.
Organization WH. Enhancing response to Omicron SARS‐CoV‐2 variant: Technical brief and priority actions for Member States; 2021.
Cloete J, Kruger A, Masha M et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: A multicentre observational study. Lancet Child Adolesc Health. 2022;6:294-302.
Higdon MM, Baidya A, Walter KK et al. Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant. Lancet Infect Dis. 2022;22:1114-1116.
Wang X, Chang H, Tian H et al. Epidemiological and clinical features of SARS-CoV-2 infection in children during the outbreak of Omicron variant in Shanghai. Influenza Other Respir Viruses. 2022;16:1059-1065.
Assessment of the further emergence of the SARS-CoV-2 Omicron VOC in the context of the ongoing Delta VOC transmission in the EU/EEA [EB/OL]. European Centre for Disease Prevention and Control.
Access on 8 Feb 2022.
Hu B, Chan JF, Liu H et al. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2. Emerg Microbes Infect. 2022;11:2275-2287.
Garcia-Beltran WF, St Denis KJ, Hoelzemer A et al. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell. 2022;185:457-466.e454.
Yamasoba D, Kimura I, Nasser H et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. Cell. 2022;185:2103-2115,e2119.
Pulliam JRC, van Schalkwyk C, Govender N et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science 2022; 376: eabn4947.
Rana R, Kant R, Huirem RS, et al. Omicron variant: Current insights and future directions. Microbiol Res. 2022;265: 127204.
Abstract View: 82 times
PDF Download: 21 times